334 related articles for article (PubMed ID: 8642250)
1. Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells.
Wen R; Cole GA; Surman S; Blackman MA; Woodland DL
J Exp Med; 1996 Mar; 183(3):1083-92. PubMed ID: 8642250
[TBL] [Abstract][Full Text] [Related]
2. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells.
Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL
J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802
[TBL] [Abstract][Full Text] [Related]
3. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
Pontzer CH; Russell JK; Johnson HM
Proc Natl Acad Sci U S A; 1991 Jan; 88(1):125-8. PubMed ID: 1986357
[TBL] [Abstract][Full Text] [Related]
5. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
[TBL] [Abstract][Full Text] [Related]
6. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
von Bonin A; Ehrlich S; Malcherek G; Fleischer B
Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
[TBL] [Abstract][Full Text] [Related]
8. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens.
Golovkina T; Agafonova Y; Kazansky D; Chervonsky A
J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278
[TBL] [Abstract][Full Text] [Related]
9. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
[TBL] [Abstract][Full Text] [Related]
10. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
11. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
12. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
[TBL] [Abstract][Full Text] [Related]
13. MHC class II-dependent abnormal reactivity toward bacterial superantigens in immune cells of NOD mice.
Radons J; Burkart V; Kolb H
Diabetes; 1997 Mar; 46(3):379-85. PubMed ID: 9032092
[TBL] [Abstract][Full Text] [Related]
14. Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1.
Braunstein NS; Weber DA; Wang XC; Long EO; Karp D
J Exp Med; 1992 May; 175(5):1301-5. PubMed ID: 1569399
[TBL] [Abstract][Full Text] [Related]
15. [Superantigens and antigen recognition of T lymphocytes].
Gülmezoğlu E
Mikrobiyol Bul; 1993 Apr; 27(2):164-70. PubMed ID: 8502189
[TBL] [Abstract][Full Text] [Related]
16. Proliferative response and cytokine production of bovine peripheral blood mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic shock syndrome toxin-1.
Yokomizo Y; Mori Y; Shimoji Y; Shimizu S; Sentsui H; Kodama M; Igarashi H
J Vet Med Sci; 1995 Apr; 57(2):299-305. PubMed ID: 7492650
[TBL] [Abstract][Full Text] [Related]
17. Superantigens interact with MHC class II molecules outside of the antigen groove.
Dellabona P; Peccoud J; Kappler J; Marrack P; Benoist C; Mathis D
Cell; 1990 Sep; 62(6):1115-21. PubMed ID: 2401011
[TBL] [Abstract][Full Text] [Related]
18. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
[TBL] [Abstract][Full Text] [Related]
19. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
Sundstedt A; Grundström S; Dohlsten M
Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
[TBL] [Abstract][Full Text] [Related]
20. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
Karp DR; Teletski CL; Scholl P; Geha R; Long EO
Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
